Suchergebnisse - "Infection"

PubPharm (18.981)

1

Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies : A meta-analysis of randomized controlled trials

enthalten in: Joint bone spine | 2024

von Séauve, M. | Auréal, M. | Laplane, S. | +3

2

Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity : A cohort study of primary care data

enthalten in: Diabetes research and clinical practice | 2024

von Carey, I. | Critchley, J. | A R Chaudhry, U. | +9

3

Infections in lung transplanted patients : A review

enthalten in: Pulmonology | 2024

von Dettori, M. | Riccardi, N. | Canetti, D. | +17

4

Health care-associated infections after surgical treatment of ruptured intracranial aneurysms

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2024

von Huang, Y. | Lee, T.

5

Neutrophils display distinct post-translational modifications in response to varied pathological stimuli

enthalten in: International immunopharmacology | 2024

von Thimmappa, P. | Nair, A. | D'silva, S. | +8

6

The therapeutic potential of thiocyanate and hypothiocyanous acid against pulmonary infections

enthalten in: Free radical biology & medicine | 2024

von Ashtiwi, N. | Kim, S. | Chandler, J. | +1

7

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. : A PHASE 3 PROSPECTIVE, RANDOMIZED, MULTICENTER, OPEN-LABEL, CENTRAL ASSESSOR-BLINDED, PARALLEL GROUP, COMPARATIVE STUDY TO DETERMINE THE EFFICACY, SAFETY AND TOLERABILITY OF AZTREONAM-AVIBACTAM (ATM-AVI) ±METRONIDAZOLE (MTZ) VERSUS MEROPENEM±COLISTIN (MER±COL) FOR THE TREATMENT OF SERIOUS INFECTIONS DUE TO GRAM NEGATIVE BACTERIA, INCLUDING METALLO-Β-LACTAMASE (MBL) - PRODUCING MULTIDRUG RESISTANT PATHOGENS, FOR WHICH THERE ARE LIMITED OR NO TREATMENT OPTIONS

enthalten in: ClinicalTrials.gov | 2024

8

PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR) : PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)

enthalten in: ClinicalTrials.gov | 2024

9

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant : Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant

enthalten in: ClinicalTrials.gov | 2024

10

HHV8 and Solid Organ Transplantation : Screening for HHV8 Infection in Solid Organ Transplantation Donors, Candidates and Recipients

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1899]